These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28665678)

  • 1. Why oncologists need technology to succeed in alternative payment models.
    Fargnoli B; Holleran R; Kolodziej M
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
    [No Abstract]   [Full Text] [Related]  

  • 2. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
    Shah S; Reh G
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
    [No Abstract]   [Full Text] [Related]  

  • 3. Hope and some skepticism whether oncology payment models will work.
    Inserro A
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP350-SP351. PubMed ID: 31860254
    [No Abstract]   [Full Text] [Related]  

  • 4. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 5. Squaring value-based payment with innovation in oncology.
    Caffrey M
    Am J Manag Care; 2018 Oct; 24(12 Spec No.):SP482-SP484. PubMed ID: 30550253
    [No Abstract]   [Full Text] [Related]  

  • 6. The Oncology Care Model-Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment.
    Lyss AJ; Supalla SN; Schleicher SM
    JAMA Oncol; 2020 Aug; 6(8):1161-1162. PubMed ID: 31670756
    [No Abstract]   [Full Text] [Related]  

  • 7. An oncologist's perspective: preparation for new payment models in cancer care.
    Apte SM
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP169-SP172. PubMed ID: 28665674
    [No Abstract]   [Full Text] [Related]  

  • 8. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 9. Making sense of advanced payment models.
    McAneny B; Grubbs SS; Birch W; Sayam Zuckerman D
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP199-SP200. PubMed ID: 28665679
    [No Abstract]   [Full Text] [Related]  

  • 10. The oncology care model and the future of alternative payment models: A gynecologic oncology perspective.
    Aviki EM; Schleicher SM; Boyd L; Liang M; Ko EM; Zanotti K; Moss H
    Gynecol Oncol; 2021 Sep; 162(3):529-531. PubMed ID: 34294415
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost of treating cancer patients: treatments versus reimbursements.
    Goldstein MG
    Md Med; 2011; 12(4):15. PubMed ID: 22455202
    [No Abstract]   [Full Text] [Related]  

  • 12. Why bundled payments could drive innovation: an example from interventional oncology.
    Steele JR; Jones AK; Ninan EP; Clarke RK; Odisio BC; Avritscher R; Murthy R; Mahvash A
    J Oncol Pract; 2015 Mar; 11(2):e199-205. PubMed ID: 25604596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Washington Brings Renewed Focus to Payment Models of the Future.
    Finerfrock B; Baugh N
    Radiol Manage; 2016; 38(3):10-1. PubMed ID: 27514104
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovative oncology products: time to revisit the strategy development?
    Krendyukov A
    ESMO Open; 2019; 4(5):e000571. PubMed ID: 31749992
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative payment and care-delivery models in oncology: A systematic review.
    Aviki EM; Schleicher SM; Mullangi S; Matsoukas K; Korenstein D
    Cancer; 2018 Aug; 124(16):3293-3306. PubMed ID: 30141837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider perspective: Stephen M. Schleicher, MD, MBA, addresses accountability versus control in Oncology Care First.
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP379-SP380. PubMed ID: 31860253
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced APMs and the emerging role of immuno-oncology agents: balancing innovation and value.
    Seiden MV; Neubauer M; Verrilli D
    Am J Manag Care; 2017 Feb; 23(2 Spec No.):SP69-SP77. PubMed ID: 28298130
    [No Abstract]   [Full Text] [Related]  

  • 19. How to value technological innovation: a proposal for determining relative clinical value.
    Ladabaum U; Brill JV; Sonnenberg A; Shaheen NJ; Inadomi J; Wilcox CM; Park WG; Hur C; Pasricha PJ
    Gastroenterology; 2013 Jan; 144(1):5-8. PubMed ID: 23153872
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing Value-Based Payment Reform: A Conceptual Framework and Case Examples.
    Conrad DA; Vaughn M; Grembowski D; Marcus-Smith M
    Med Care Res Rev; 2016 Aug; 73(4):437-57. PubMed ID: 26545852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.